DK0804229T3 - Anvendelse af amlodipin, et salt deraf eller felodipin i kombination med en ACE-inhibitor til fremstilling af et medikament til behandling af non-ikæmisk kongestiv hjertefejl - Google Patents

Anvendelse af amlodipin, et salt deraf eller felodipin i kombination med en ACE-inhibitor til fremstilling af et medikament til behandling af non-ikæmisk kongestiv hjertefejl

Info

Publication number
DK0804229T3
DK0804229T3 DK96901940T DK96901940T DK0804229T3 DK 0804229 T3 DK0804229 T3 DK 0804229T3 DK 96901940 T DK96901940 T DK 96901940T DK 96901940 T DK96901940 T DK 96901940T DK 0804229 T3 DK0804229 T3 DK 0804229T3
Authority
DK
Denmark
Prior art keywords
amlodipine
heart failure
congestive heart
felodipine
medicament
Prior art date
Application number
DK96901940T
Other languages
English (en)
Inventor
Anne B Cropp
Allen R Kraska
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0804229T3 publication Critical patent/DK0804229T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK96901940T 1995-03-16 1996-02-26 Anvendelse af amlodipin, et salt deraf eller felodipin i kombination med en ACE-inhibitor til fremstilling af et medikament til behandling af non-ikæmisk kongestiv hjertefejl DK0804229T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40510895A 1995-03-16 1995-03-16
PCT/IB1996/000145 WO1996028185A2 (en) 1995-03-16 1996-02-26 Composition containing amlodipine, or a salt, or felodipine and an ace inhibitor

Publications (1)

Publication Number Publication Date
DK0804229T3 true DK0804229T3 (da) 2003-04-22

Family

ID=23602311

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96901940T DK0804229T3 (da) 1995-03-16 1996-02-26 Anvendelse af amlodipin, et salt deraf eller felodipin i kombination med en ACE-inhibitor til fremstilling af et medikament til behandling af non-ikæmisk kongestiv hjertefejl

Country Status (12)

Country Link
US (1) US6245787B1 (da)
EP (1) EP0804229B1 (da)
JP (2) JPH11500140A (da)
AT (1) ATE235251T1 (da)
CA (1) CA2215234C (da)
DE (1) DE69626958T2 (da)
DK (1) DK0804229T3 (da)
ES (1) ES2193233T3 (da)
FI (1) FI973691A (da)
MX (1) MX9706957A (da)
PT (1) PT804229E (da)
WO (1) WO1996028185A2 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721263A (en) * 1993-06-07 1998-02-24 Takeda Chemical Industries, Ltd. Pharmaceutical composition for angiotensin II-mediated diseases
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
EP0795327A1 (en) * 1996-03-13 1997-09-17 Pfizer Inc. Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin
FR2771010B1 (fr) * 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
US6521647B2 (en) 2000-04-04 2003-02-18 Pfizer Inc. Treatment of renal disorders
GB0008332D0 (en) * 2000-04-04 2000-05-24 Pfizer Ltd Treament
WO2002051441A1 (fr) * 2000-12-26 2002-07-04 Sankyo Company, Limited Compositions medicinales contenant un diuretique et un agent renforçant la resistance a l'insuline
PE20040468A1 (es) * 2002-05-17 2004-09-14 Novartis Ag Combinacion de compuestos organicos
US20040072879A1 (en) * 2002-10-10 2004-04-15 Dr. Reddy's Laboratories Limited Crystalline 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine maleate salt (Amlodipine)
HUP0401170A2 (en) * 2004-06-10 2006-09-28 Richter Gedeon Vegyeszet Pharmaceutical composition comprising amlodipine besilate and lisinopril dihydrate and process for
US8158146B2 (en) 2005-09-28 2012-04-17 Teva Pharmaceutical Industries Ltd. Stable combinations of amlodipine besylate and benazepril hydrochloride
US20070142473A1 (en) * 2005-12-15 2007-06-21 Lawrence Solomon Dosage forms and methods using ethacrynic acid
US20110086092A1 (en) * 2006-08-08 2011-04-14 Accu-Break Technologies, Inc. Pharmacuetical tablets containing a plurality of active ingredients
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
CA2790817A1 (en) 2010-02-24 2011-09-01 Sanofi-Aventis Deutschland Gmbh Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation
RU2483728C1 (ru) * 2011-09-29 2013-06-10 Общество с ограниченной ответственностью "Озон" Комбинированное гипотензивное средство и способ его получения
WO2015153379A1 (en) * 2014-04-01 2015-10-08 Ailex Pharmaceuticals, Pvt. Ltd. Fiixed dosage formulations of angiotensin converting enzyme (ace) inhibitor and the diuretic chlorthalidone
US11452690B1 (en) 2021-01-27 2022-09-27 ECI Pharmaceuticals, LLC Oral liquid compositions comprising amlodipine besylate and methods of using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
US5155120A (en) 1991-01-14 1992-10-13 Pfizer Inc Method for treating congestive heart failure
NZ242724A (en) 1991-05-15 1994-09-27 Du Pont Synergistic composition comprising an angiotensin-ii receptor antagonist and a calcium channel blocker
EP0795327A1 (en) 1996-03-13 1997-09-17 Pfizer Inc. Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin

Also Published As

Publication number Publication date
WO1996028185A2 (en) 1996-09-19
JPH11500140A (ja) 1999-01-06
MX9706957A (es) 1997-11-29
JP2003286170A (ja) 2003-10-07
PT804229E (pt) 2003-06-30
ES2193233T3 (es) 2003-11-01
FI973691A0 (fi) 1997-09-15
WO1996028185A3 (en) 1996-10-17
DE69626958D1 (de) 2003-04-30
DE69626958T2 (de) 2004-03-18
FI973691A (fi) 1997-09-15
ATE235251T1 (de) 2003-04-15
CA2215234A1 (en) 1996-09-19
EP0804229A2 (en) 1997-11-05
US6245787B1 (en) 2001-06-12
EP0804229B1 (en) 2003-03-26
CA2215234C (en) 2001-12-11

Similar Documents

Publication Publication Date Title
DK0804229T3 (da) Anvendelse af amlodipin, et salt deraf eller felodipin i kombination med en ACE-inhibitor til fremstilling af et medikament til behandling af non-ikæmisk kongestiv hjertefejl
DK0509019T3 (da) Behandling af humane retrovirale infektioner med 2',3'-dideoxyinosin
LV10878A (lv) Adas apstradasana ar izveletiem amfifiliem kopolimeriem
FI925342A0 (fi) Menetelmä terapeuttisesti aktiivisen (+)- -(2,3-dimetoksifenyyli)-1-/2-(4-fluorifenyyli)etyyli/-4-piperidiinimetanolin valmistamiseksi
ITRM920412A1 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiego terapeutico.
DE69814394D1 (de) Verwendung von levobupivacain
ATE252885T1 (de) Plan zur verabreichung von h+, k+-atpase inhibitoren
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
NO952828D0 (no) Synergiserende blanding med en antagonist-virkning på NK1- og NK2-reseptorer
EP1262175A3 (en) Use of renin-angiotensin antagonist for reducing post myocardial infarct mobidity and mortality
DK0799618T3 (da) Anvendelse af alpha1-adrenoreceptor-antagonister i fremstillingen af et medikament til forebyggelsen og behandlingen af cancer
DK694188A (da) Anvendelse af ace-inhibitor til laegemiddelfremstilling, evt. i kombination med et calciumkanalblokeringsmiddel
IS4174A (is) Ný notkun á lyfjafræðilega viðurkenndu salti
DK0862454T3 (da) CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner
DK0458587T3 (da) Behandling af okulær hypertension med en synergistisk kombination til ophthalmisk anvendelse
DK578789A (da) Pyrrolidin-2-carboxylsyre-derivater med psykotrop virkning, deres fremstilling og anvendelse
DK1058544T3 (da) Inhibition af TNF-aktivitet med præparater, der omfatter heparin og oplöselige TNF-receptorer
IT8819958A0 (it) Derivati alchiltiobenzimidazolici attivi farmacologicamente eprocedimento per la loro preparazione.
DE68906245D1 (de) Therapeutisches mittel gegen aids.
MX9202595A (es) Derivado de nucleosido.
DE69626510D1 (de) Verwendung des leukämie-inhibitor-faktor und endothelin antagonisten
ES2041987T3 (es) Metodo y composicion para analgesia oftalmica empleando rodocaina.
SE9602262D0 (sv) New use of derivatives of cystine
DK0711163T3 (da) Anvendelse af benzydamin i behandlingen af patologiske tilstande forårsaget af TNF
NO985695L (no) Formulering og fremgangsmÕte for Õ behandle kongestiv hjerteinfarkt